SG11201903097UA - Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition - Google Patents

Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition

Info

Publication number
SG11201903097UA
SG11201903097UA SG11201903097UA SG11201903097UA SG11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA
Authority
SG
Singapore
Prior art keywords
international
composition
moscow
antiseptic
pct
Prior art date
Application number
SG11201903097UA
Inventor
Anna Gennadievna Afinogenova
Gennady Evgenievich Afinogenov
Tamaz Omarovich Manasherov
Svetlana Konstantinovna Matelo
Original Assignee
Medid Innovation Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medid Innovation Dev Ltd filed Critical Medid Innovation Dev Ltd
Publication of SG11201903097UA publication Critical patent/SG11201903097UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Abstract

OO O (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 30 August 2018 (30.08.2018) WIPO I PCT 0111111010 0111 °nolo monivoinumflo oimIE (10) International Publication Number WO 2018/156051 Al (51) International Patent Classification: A61K 31/79 (2006.01) A61K 9/70 (2006.01) A61K 31/047 (2006.01) A61K 31/235 (2006.01) A61K 31/185 (2006.01) A61P 17/02 (2006.01) A61K 31/167 (2006.01) A61K 45/06 (2006.01) A61K 9/00 (2006.01) A61K 31/14 (2006.01) A61K 9/06 (2006.01) A61K 31/517 (2006.01) A61K 47/42 (2017.01) A61K 31/10 (2006.01) (21) International Application Number: PCT/RU2017/000905 (22) International Filing Date: 14 December 2017 (14.12.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 2017106061 22 February 2017 (22.02.2017) RU (71) Applicant: OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'YU \"WDS\" [RU/RU]; ul. Ku- lakova, 20-1G, Moscow, 123592 (RU). (72) Inventors: AFINOGENOVA, Anna Gennadievna; ul. Kujysheva, 23-39, St. Petersburg, 197046 (RU). AFINOGENOV, Gennady Evgenievich; ul. Kujbyshe- va, 23-39, St. Petersburg, 197046 (RU). MANASHEROV, Tamaz Omarovich; Universitetsky prosp., 9-75, Moscow, 119296 (RU). MATELO, Svetlana Konstantinovna; 25-70 Krasnogorsk district, Moscow region, Mechnikovo, 143442 (RU). (74) Agent: SOJUZPATENT et al.; Myasnitskaya Str., 13, bldg. 5, Moscow, 101000 (RU). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (54) Title: ANTISEPTIC COMPOSITION COMPRISING POLYVINYLPYRROLIDONE AND UNITHIOL AND USE OF THE COMPOSITION Fig. 7 (57) : The invention relates to novel polymer-based antiseptic compositions for treating wounds and/or for use in surgical operations, which form a film on the wound surface and have antiseptic, anesthetic and antitoxic effects. The compositions according to the invention comprise polyvinylpyrrolidone with a weight average molecular weight in the range of 1,000,000 to 3,000,000 Da, one or more antiseptics, unithiol, dimethylsulfoxide, and one or more anesthetics, preferably local anesthetics. In addition, the present invention relates to use of the compositions according to the invention in a wound treatment, as well as methods for treating wounds using the compositions according to the invention comprising the step of applying the composition according to the invention to a wound surface. [Continued on next page] WO 2018/156051 Al MIDEDIM000101011EUMM0MOUDIE0IREM011111110110111111 MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
SG11201903097UA 2017-02-22 2017-12-14 Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition SG11201903097UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2017106061A RU2649785C1 (en) 2017-02-22 2017-02-22 Antiseptic composition containing polyvinyl pyrrolidone and unitiol, application of such a composition and method of wound treatment with the use of it
PCT/RU2017/000905 WO2018156051A1 (en) 2017-02-22 2017-12-14 Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition

Publications (1)

Publication Number Publication Date
SG11201903097UA true SG11201903097UA (en) 2019-09-27

Family

ID=61094570

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201903097UA SG11201903097UA (en) 2017-02-22 2017-12-14 Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition

Country Status (19)

Country Link
US (1) US11045551B2 (en)
EP (1) EP3585399B1 (en)
JP (1) JP6690816B2 (en)
KR (1) KR102096257B1 (en)
CN (1) CN110198721B (en)
AU (1) AU2017400650B2 (en)
BR (1) BR112019016560A2 (en)
CA (1) CA3054002C (en)
CL (1) CL2019002259A1 (en)
EA (1) EA037319B1 (en)
GE (1) GEP20207136B (en)
MA (1) MA46159B1 (en)
MX (1) MX2019009761A (en)
PL (1) PL3585399T3 (en)
RU (1) RU2649785C1 (en)
SG (1) SG11201903097UA (en)
UA (1) UA121949C2 (en)
WO (1) WO2018156051A1 (en)
ZA (1) ZA201905343B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2713884C1 (en) * 2018-12-18 2020-02-10 Екатерина Николаевна Мехоношина Liquid composition for producing a spray for forming an antimicrobial wound dressing in skin microtrauma

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739922A (en) * 1952-03-13 1956-03-27 Herman A Shelanski Mixtures of polymeric n-vinyl pyrrolidone and halogens
US3761590A (en) 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns
GB2148901A (en) 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
RU2062113C1 (en) * 1993-10-19 1996-06-20 Владимир Валентинович Рыльцев Method for producing bandage materials
RU2088234C1 (en) 1994-11-25 1997-08-27 Институт высокомолекулярных соединений РАН Water-soluble bactericidal composition and a method of its preparing
UA13954C2 (en) * 1996-06-13 2001-05-15 Державний Науковий Центр Лікарських Засобів Antibacterial drug for topical use
RU2185155C2 (en) 2000-04-27 2002-07-20 Кривошеин Юрий Семенович Antiseptic wound-healing glue
US6828308B2 (en) * 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
RU2175549C1 (en) * 2000-10-26 2001-11-10 Закрытое акционерное общество "ТОП-ВЕТ" Wound-healing medicinal preparation "zooderm"
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
RU2284824C1 (en) * 2005-03-18 2006-10-10 Общество с ограниченной ответственностью "Сирена" Surgical antiseptic glue "argacol"
WO2006121219A1 (en) * 2005-05-13 2006-11-16 Osaka University Agent for controlling epithelial-mesenchymal transition
US8377468B2 (en) * 2006-08-28 2013-02-19 Rexaderm, Inc. Dry wound dressing and drug delivery system
RU2403921C1 (en) * 2009-04-01 2010-11-20 Государственное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Method of combination therapy of circumscribed sclerodermia with applying local transdermal enzymic electrostatic exposure
RU2404781C1 (en) * 2009-07-23 2010-11-27 Институт элементоорганических соединений РАН (ИНЭОС РАН) Composition as antibacterial agent, method for production of material on its basis and macroporous antibacterial material based on this composition
CN103505470A (en) * 2012-06-22 2014-01-15 江苏胜意药业有限公司 Production method for povidone-iodine solution
CN113559105A (en) * 2014-01-29 2021-10-29 维奥姆治疗有限公司 Treatment of resistant acne
RU2545915C1 (en) * 2014-02-14 2015-04-10 Олег Васильевич Рубальский Method of treating chronic pain syndrome
RU2545798C1 (en) * 2014-03-24 2015-04-10 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Pharmaceutical composition for immediate treatment of burns of various origins, area and depth in form of spray, gel and aerosol
RU2603490C1 (en) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
RU2605343C1 (en) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes

Also Published As

Publication number Publication date
CN110198721A (en) 2019-09-03
US20190381176A1 (en) 2019-12-19
CA3054002A1 (en) 2018-08-30
MX2019009761A (en) 2019-10-07
KR20190099338A (en) 2019-08-26
CA3054002C (en) 2021-07-20
UA121949C2 (en) 2020-08-10
CL2019002259A1 (en) 2020-01-03
EP3585399B1 (en) 2022-02-09
AU2017400650A1 (en) 2019-07-18
JP2020506164A (en) 2020-02-27
ZA201905343B (en) 2021-08-25
EA201991275A1 (en) 2019-11-29
EP3585399A1 (en) 2020-01-01
BR112019016560A2 (en) 2020-03-31
JP6690816B2 (en) 2020-04-28
WO2018156051A1 (en) 2018-08-30
CN110198721B (en) 2022-06-07
MA46159A1 (en) 2021-04-30
PL3585399T3 (en) 2022-05-30
US11045551B2 (en) 2021-06-29
AU2017400650B2 (en) 2019-09-26
KR102096257B1 (en) 2020-04-06
EA037319B1 (en) 2021-03-11
MA46159B1 (en) 2022-04-29
GEP20207136B (en) 2020-07-27
RU2649785C1 (en) 2018-04-04

Similar Documents

Publication Publication Date Title
SG11201804312RA (en) Microbubble-chemotherapeutic agent complex for sonodynamic therapy
SG11201906297QA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201804373VA (en) Compositions and methods for immunooncology
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201810579YA (en) Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders
SG11202000266VA (en) Quinoline derivatives for treating infections with helminths
SG11201810280YA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201806868TA (en) Compositions and methods for protecting against airborne pathogens and irritants
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201806968RA (en) Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
SG11201906222WA (en) Jak1 selective inhibitors
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201805001UA (en) Method of treating influenza a
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201804587QA (en) Isoindole compounds
SG11201811209QA (en) Oral gastroretentive formulations and uses thereof
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201908691PA (en) Compounds and methods for the treatment of parasitic diseases
SG11201901249YA (en) Aza-indazole compounds for use in tendon and/or ligament injuries
SG11201908065YA (en) Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
SG11201809875VA (en) Compositions and methods for treating spinal muscular atrophy